comparemela.com

Latest Breaking News On - Bellicum pharmaceuticals inc - Page 1 : comparemela.com

Bellicum Pharmaceuticals (NASDAQ:BLCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % Shares of BLCM opened at $0.07 on Friday. The business’s 50 day moving average is $0.08 and […]

United-states
Bellicum-pharmaceuticals-stock-down
Bellicum-pharmaceuticals
Bellicum-pharmaceuticals-inc
Bellicum-pharmaceuticals-company-profile
News-ratings-for-bellicum-pharmaceuticals-daily
Boxer-capital
Nasdaq
Free-report
Pharmaceuticals-stock-down
Get-free-report

StockNews.com Initiates Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)

StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Stock Down 6.6 % NASDAQ:BLCM opened at $0.07 on Friday. The stock’s 50-day simple moving average is $0.08 and its 200 […]

United-states
Bellicum-pharmaceuticals-stock-down
Bellicum-pharmaceuticals
Institutional-trading-of-bellicum-pharmaceuticals
Bellicum-pharmaceuticals-inc
Bellicum-pharmaceuticals-company-profile
News-ratings-for-bellicum-pharmaceuticals-daily
Exchange-commission
Boxer-capital
Nasdaq
Free-report

StockNews.com Begins Coverage on Bellicum Pharmaceuticals (NASDAQ:BLCM)

StockNews.com assumed coverage on shares of Bellicum Pharmaceuticals (NASDAQ:BLCM – Free Report) in a report released on Saturday. The firm issued a sell rating on the biopharmaceutical company’s stock. Bellicum Pharmaceuticals Trading Down 6.6 % Shares of BLCM stock opened at $0.07 on Friday. Bellicum Pharmaceuticals has a 12 month low of $0.06 and a […]

United-states
Boxer-capital
Bellicum-pharmaceuticals-trading-down
Institutional-investors-weigh-in-on-bellicum-pharmaceuticals
Securities-exchange-commission
Bellicum-pharmaceuticals
Nasdaq
Bellicum-pharmaceuticals-inc
News-ratings-for-bellicum-pharmaceuticals-daily
Free-report
Pharmaceuticals-trading-down

Bellicum Pharmaceuticals (NASDAQ:BLCM) Receives New Coverage from Analysts at StockNews.com

Bellicum Pharmaceuticals (NASDAQ:BLCM) Receives New Coverage from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states
Institutional-investors-weigh-in-on-bellicum-pharmaceuticals
Bellicum-pharmaceuticals
Nasdaq
Bellicum-pharmaceuticals-inc
News-ratings-for-bellicum-pharmaceuticals-daily
Bellicum-pharmaceuticals-trading-down
Securities-exchange-commission
Boxer-capital
Free-report
Pharmaceuticals-trading-down

MD Anderson acquires cell therapy safety technology from Bellicum Pharmaceuticals

The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe switch platform and the GoCAR platform.

University-of-texas
Texas
United-states
Bellicum-go
Katy-rezvani
Philip-jones
Cancer-center
Drug-administration
Research-strategy
Bellicum-pharmaceuticals-inc
Manderson-cancer
Bellicum-pharmaceuticals

vimarsana © 2020. All Rights Reserved.